Cost-Effectiveness of Azacitidine and Ivosidenib in Newly Diagnosed Older, Intensive Chemotherapy-Ineligible Patients with IDH1-Mutant Acute Myeloid Leukemia

Saved in:
Bibliographic Details
Published inBlood Vol. 140; no. Supplement 1; pp. 319 - 321
Main Authors Bewersdorf, Jan Philipp, Patel, Kishan K, Goshua, George, Shallis, Rory Michael, Podoltsev, Nikolai A., Stahl, Maximilian F., Stempel, Jessica M., Stein, Eytan, Huntington, Scott F., Zeidan, Amer M.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 15.11.2022
Online AccessGet full text

Cover

More Information
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-158465